Pre-market Hot Trades in US Stocks
Roadzen is up 8.72% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 4, Roadzen announced a securities purchase agreement with institutional investors involving 4.7 million shares of common stock, priced at $1.70 per share. This move is expected to bring approximately $8 million in total revenue to the company, enhancing its market position.
</li>
<li>
On May 4, Roadzen will participate in the VECS 2026 conference in Gothenburg, Sweden, and attend an exclusive reception hosted by Business Sweden. This event brings together executives from AI, automotive manufacturers, and the mobility industry, indicating the company's strategic expansion in the European market.
</li>
<li>
On May 1, Roadzen plans to attend the VECS 2026 conference from May 5 to 6, further showcasing its innovative capabilities in AI technology and the insurance sector. The application prospects of AI technology in the insurance field are broad.
</li>
</ol>
DigitalOcean is up 8.48% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 5, DigitalOcean announced its first-quarter financial report, showing a total profit of $144.71 million, exceeding market expectations of $249.7 million, driving the stock price up. Source: Reuters
</li>
<li>
On May 4, positive investor sentiment in the data analytics software sector propelled DigitalOcean's stock price up 20%, and its peer Commvault's performance exceeded expectations, further boosting market confidence. Source: MarketBeat
</li>
<li>
On May 2, although DigitalOcean received a moderate buy rating from analysts, top analysts believe there are five stocks that are more attractive, which may have some impact on the stock price. Source: MarketBeat The data analytics software industry is performing strongly, with positive investor sentiment.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Cellectar Biosciences is up 96.11% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 5, Cellectar Biosciences announced significant progress in clinical trials for its new drug CLRB-123. The drug has shown significant efficacy, driving the stock price sharply higher. Source: GlobeNewswire
</li>
<li>
On May 5, the company released its latest financial report, showing that both its revenue and profit exceeded market expectations. Strong financial performance further boosted investor confidence. Source: GlobeNewswire
</li>
<li>
On May 5, analysts generally upgraded Cellectar Biosciences' rating, expecting its future performance to continue growing. Positive rating changes provided strong support for the stock price. Source: GlobeNewswire The biotechnology industry has performed strongly recently, with noticeable capital inflows
Sadot pre-market rose 62.07%. Based on recent key news:
</li>
<li>
On May 3, Four Pillars raised funds in its Series A financing. Although the specific amount was not disclosed, as a research-driven blockchain company, Four Pillars helps enterprises efficiently implement blockchain technology, providing technical, legal, and market analysis support. This news may have boosted market confidence in blockchain-related companies, driving Sadot's stock price significantly higher.
</li>
<li>
No other significant news recently.
</li>
<li>
No other significant news recently. The blockchain industry has performed strongly lately, with noticeable capital inflows.
</li>
</ol>
Backblaze pre-market rose 42.24%. Based on recent key news:
<ol>
<li>
On May 5, Backblaze announced first-quarter revenue of $38.7 million, exceeding market expectations of $37.8 million. The company benefited from AI-related demand, with B2 cloud storage business growing 24%, driving the stock price up. Source: Reuters
</li>
<li>
On May 5, Backblaze raised its full-year revenue and adjusted EBITDA margin guidance, reflecting confidence in continued growth. The company expects revenue in 2026 to be between $161.5 million and $163.5 million, higher than previously estimated. Source: SEC announcement
</li>
<li>
On May 5, Backblaze management emphasized during the earnings call that the growth of AI customers and market transformation accelerated the development of the B2 business, further enhancing market confidence. Source: Earnings Call Transcript AI demand drives growth in the cloud storage industry
</li>
</ol>

RDZN

DOCN

Roadzen pre-market up 8.72%; Digitalocean pre-market up 8.48%; Cellectar Biosciences pre-market up 96.11%; Sadot pre-market up 62.07%; Backblaze pre-market up 42.24%

Price Alert

Roadzen

Pre-market hot trades in US stocks: Roadzen up 8.72% in pre-market; Digitalocean up 8.48% in pre-market